NCT00189124View on ClinicalTrials.gov

Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

July 31, 2006

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Dehydroepiandrosterone (DHEA)

Trial Locations (1)

48109

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

Arthritis Foundation
All Listed Sponsors
collaborator

Arthritis Foundation

OTHER

lead

University of Michigan

OTHER

NCT00189124 - Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention | Biotech Hunter | Biotech Hunter